4-3074876-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP3BP6_ModerateBS1BS2
The NM_001388492.1(HTT):c.90_110dupGCAGCAGCAGCAGCAGCAGCA(p.Gln31_Gln37dup) variant causes a disruptive inframe insertion change. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.010 ( 11 hom., cov: 0)
Exomes 𝑓: 0.0036 ( 20 hom. )
Consequence
HTT
NM_001388492.1 disruptive_inframe_insertion
NM_001388492.1 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.84
Publications
6 publications found
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001388492.1
BP6
Variant 4-3074876-C-CCAGCAGCAGCAGCAGCAGCAG is Benign according to our data. Variant chr4-3074876-C-CCAGCAGCAGCAGCAGCAGCAG is described in ClinVar as [Likely_benign]. Clinvar id is 3910360.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0101 (1333/131868) while in subpopulation NFE AF = 0.0119 (730/61482). AF 95% confidence interval is 0.0112. There are 11 homozygotes in GnomAd4. There are 602 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR,AD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTT | NM_001388492.1 | c.90_110dupGCAGCAGCAGCAGCAGCAGCA | p.Gln31_Gln37dup | disruptive_inframe_insertion | Exon 1 of 67 | ENST00000355072.11 | NP_001375421.1 | |
HTT | NM_002111.8 | c.90_110dupGCAGCAGCAGCAGCAGCAGCA | p.Gln31_Gln37dup | disruptive_inframe_insertion | Exon 1 of 67 | NP_002102.4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0101 AC: 1332AN: 131770Hom.: 10 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
1332
AN:
131770
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00357 AC: 4374AN: 1225744Hom.: 20 Cov.: 0 AF XY: 0.00383 AC XY: 2330AN XY: 608074 show subpopulations
GnomAD4 exome
AF:
AC:
4374
AN:
1225744
Hom.:
Cov.:
0
AF XY:
AC XY:
2330
AN XY:
608074
show subpopulations
African (AFR)
AF:
AC:
67
AN:
25812
American (AMR)
AF:
AC:
168
AN:
30302
Ashkenazi Jewish (ASJ)
AF:
AC:
109
AN:
22732
East Asian (EAS)
AF:
AC:
69
AN:
29088
South Asian (SAS)
AF:
AC:
306
AN:
72222
European-Finnish (FIN)
AF:
AC:
265
AN:
32498
Middle Eastern (MID)
AF:
AC:
22
AN:
3780
European-Non Finnish (NFE)
AF:
AC:
3085
AN:
957480
Other (OTH)
AF:
AC:
283
AN:
51830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
128
257
385
514
642
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0101 AC: 1333AN: 131868Hom.: 11 Cov.: 0 AF XY: 0.00949 AC XY: 602AN XY: 63418 show subpopulations
GnomAD4 genome
AF:
AC:
1333
AN:
131868
Hom.:
Cov.:
0
AF XY:
AC XY:
602
AN XY:
63418
show subpopulations
African (AFR)
AF:
AC:
295
AN:
35520
American (AMR)
AF:
AC:
158
AN:
13410
Ashkenazi Jewish (ASJ)
AF:
AC:
26
AN:
3188
East Asian (EAS)
AF:
AC:
13
AN:
4124
South Asian (SAS)
AF:
AC:
29
AN:
3908
European-Finnish (FIN)
AF:
AC:
58
AN:
7368
Middle Eastern (MID)
AF:
AC:
3
AN:
252
European-Non Finnish (NFE)
AF:
AC:
730
AN:
61482
Other (OTH)
AF:
AC:
21
AN:
1816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
58
116
175
233
291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.